OXCARP 300 mg Price

Overview

Welcome to Dwaey, specifically on OXCARP 300 mg Injection/Intraarticular page.
This medicine contains an important and useful components, as it consists of Oxcarbazepine.
OXCARP 300 mg is available in the market in concentration 300 mg/tablet and in the form of Injection/Intraarticular.

ANNORA PHARMA FZ-LLC is the producer of OXCARP 300 mg and it is imported from UAE, The most popular alternatives of OXCARP 300 mg are listed downward .

Mode Of Action

Oxcarbazepine blocks voltage-sensitive sodium channels, which inhibits repetitive firing, stabilises hyperexcited neuronal membranes and decreases release of synaptic impulses. These effects may prevent the spread of epileptic seizures.

Indication

• Partial seizures
• Generalised tonic-clonic seizures

Precaution

Patient carrying the HLA-B*1502 allele. Avoid abrupt withdrawal. Severe renal and hepatic impairment. Pregnancy. Patient Counselling May impair ability to drive or operate machinery. Monitoring Parameters Monitor seizure frequency, serum Na, symptoms of CNS depression, hypersensitivity reactions, serum levels of concomitant antiepileptic drugs during titration; periodic thyroid function test and CBC. Lactation: Oxcarbazepine and its active metabolite (MHD) are excreted in human milk; milk-to-plasma concentration ratio of 0.5 was found for both Because of the potential for serious adverse reactions in nursing infants, a decision should be made as to whether a mother should discontinue nursing or whether she should discontinue use of the drug, taking into account the drug's importance to the mother

Side Effects

• >10% Dizziness (30-50%)
• Diplopia (30-50%)
• Headache (26-30%)
• Nausea/vomiting (26-30%)
• Nystagmus (26-30%)
• Somnolence (26-30%)
• Ataxia (10-30%)
• Abnormal gait (16-20%)
• Tremor (16-20%)
• Abdominal pain (11-15%)
• Fatigue (11-15%)
• Vertigo (11-15%)
• Vision abnormalities (11-15%) 1-10% Dyspepsia (5-6%)
• Rash (4%)
• Insomnia (2-4%)
• Abnormal thinking (<4%)
• Hyponatremia (1-3%)
• Muscle weakness (1-2%)
• Hypotension (<2%)
• Speech disorder (1%)
• Asthenia

Contra indication

Hypersensitivity. Lactation.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks